CORRECTION article

Front. Psychiatry, 19 July 2022

Sec. Psychopharmacology

Volume 13 - 2022 | https://doi.org/10.3389/fpsyt.2022.962882

Corrigendum: A cohort-based case report: The impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression

  • 1. Health and Human Services, Vancouver Island University, Nanaimo, BC, Canada

  • 2. Private Practice, Duncan, BC, Canada

Article metrics

View details

4

Citations

2,3k

Views

930

Downloads

In the published article, there was an error in Figure 2 as published. The PTSD labels in the pre- and post- rows of the figure were incorrectly positioned underneath the Anxiety score, and vice versa. The corrected version of Figure 2 and its caption is published below.

Figure 2

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

ketamine-assisted psychotherapy, healthcare providers (HCP), resilience, psychedelic therapy, group therapy, community of practice, post-traumatic stress disorder (PTSD), depression

Citation

Dames S, Kryskow P and Watler C (2022) Corrigendum: A cohort-based case report: The impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression. Front. Psychiatry 13:962882. doi: 10.3389/fpsyt.2022.962882

Received

06 June 2022

Accepted

01 July 2022

Published

19 July 2022

Volume

13 - 2022

Edited and reviewed by

Celia J. A. Morgan, University of Exeter, United Kingdom

Updates

Copyright

*Correspondence: Shannon Dames

This article was submitted to Psychopharmacology, a section of the journal Frontiers in Psychiatry

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics